HAE
Haemonetics Corporation
NYSE: HAE · HEALTHCARE · MEDICAL DEVICES
$52.67
-5.30% today
Updated 2026-05-06
Market cap
$2.75B
P/E ratio
16.33
P/S ratio
2.09x
EPS (TTM)
$3.63
Dividend yield
—
52W range
$47 – $87
Volume
0.7M
Haemonetics Corporation (HAE) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+7.4%
Last 4 quarters
Revenue YoY growth
-2.7%
Most recent quarter
EPS YoY growth
+28.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+34.8%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-05 | $0.95 | +5.6% | $65.95 | $59.34 | -10.0% |
| 2025-11-06 | $1.27 | +14.4% | $50.72 | $68.36 | +34.8% |
| 2025-08-07 | $1.10 | +7.8% | $75.77 | $53.99 | -28.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.90 | $0.95 | +5.6% | $338.97M | -2.7% |
| 2025-09-30 | $1.11 | $1.27 | +14.4% | $327.31M | -5.3% |
| 2025-06-30 | $1.02 | $1.10 | +7.8% | $321.39M | -4.4% |
| 2025-03-31 | $1.22 | $1.24 | +1.6% | $330.60M | -3.7% |
| 2024-12-31 | $0.91 | $0.74 | -18.7% | $348.54M | +3.7% |
| 2024-09-30 | $0.77 | $0.66 | -14.3% | $345.51M | +8.6% |
| 2024-06-30 | $1.01 | $1.02 | +1.0% | $336.17M | +8.0% |
| 2024-03-31 | $0.89 | $0.90 | +1.1% | $343.29M | — |
| 2023-12-31 | $0.94 | $1.04 | +10.6% | $336.25M | — |
| 2023-09-30 | $0.89 | $0.99 | +11.2% | $318.18M | — |
| 2023-06-30 | $0.73 | $1.05 | +43.8% | $311.33M | — |
Frequently asked questions
Has Haemonetics Corporation beaten earnings estimates?
Haemonetics Corporation has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +7.4% over the last 4 quarters.
How does HAE stock react to earnings?
HAE stock has moved an average of -1.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Haemonetics Corporation's revenue growth rate?
Haemonetics Corporation reported year-over-year revenue growth of -2.7% in its most recent quarter, with EPS growing +28.4% year-over-year.